Arne Engelsberg

Pfizer (Germany) — Germany

Medicine · Health Sciences

11h-index1.6kcitations21works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(4), Polyomavirus and related diseases(4), PARP inhibition in cancer therapy(4), Cancer Immunotherapy and Biomarkers(3), Immunotherapy and Immune Responses(3)

Publications21 total

Discovery of a novel non-negative matrix factorization (NMF)-based homologous recombination deficiency (HRD) score and subsequent exploration in TALAPRO-2 (TP-2), a phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2024· 1 cited
Abstract CT018: TMPRSS2-ERG and RB1 as candidate predictive biomarkers for efficacy in TALAPRO-2: Phase 3 study of talazoparib (TALA) + enzalutamide (ENZA) vs placebo (PBO) + ENZA as first-line (1L) treatment in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Cancer Research·2024· 4 cited
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer
European Journal of Cancer·2023· 31 citedOpen Access
Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Safety analyses from the randomized, placebo (PBO)-controlled, phase 3 TALAPRO-2 study.
Journal of Clinical Oncology·2023· 6 cited
Correction: <i>Phase 2 study of pembrolizumab in patients with advanced rare cancers</i>
Journal for ImmunoTherapy of Cancer·2020· 9 citedOpen Access
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program
Journal for ImmunoTherapy of Cancer·2020· 81 citedOpen Access
Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad hoc expanded access program (EAP)
Annals of Oncology·2018· 1 citedOpen Access
Prise en charge du carcinome à cellules de Merkel métastatique en 2e ligne : résultats de l’autorisation temporaire d’utilisation de cohorte en France
Annales de Dermatologie et de Vénéréologie·2018
Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad-hoc expanded access program (EAP)
Annals of Oncology·2018· 3 citedOpen Access
Cross-over—it's a feature, not a bug
Annals of Oncology·2015· 1 citedOpen Access
Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus
Lung Cancer·2014· 45 citedOpen Access
Different Motifs Regulate Trafficking of SorCS1 Isoforms
Traffic·2008· 44 citedOpen Access
SorCS1 isoforms are internalized via different motifs and deliver cargo to lysosomes
GBM Annual Spring meeting Mosbach 2007·2007
Funktionelle Charakterisierung der Serum- und Glukokortikoid-induzierbaren Proteinkinase Sgk1
2007Open Access
Arc/Arg3.1 Is Essential for the Consolidation of Synaptic Plasticity and Memories
Neuron·2006· 830 citedOpen Access
The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover
Biochemical Journal·2006· 30 citedOpen Access
EBAG9 Adds a New Layer of Control on Large Dense-Core Vesicle Exocytosis via Interaction with Snapin
Molecular Biology of the Cell·2005· 41 citedOpen Access
The Golgi Protein RCAS1 Controls Cell Surface Expression of Tumor-associated O-Linked Glycan Antigens
Journal of Biological Chemistry·2003· 61 citedOpen Access
5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
PubMed·2002· 143 cited
Human Cytomegalovirus Gene Products US2 and US11 Differ in Their Ability To Attack Major Histocompatibility Class I Heavy Chains in Dendritic Cells
Journal of Virology·2002· 68 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Dietmar Kuhl(4), Luc Dirix(4), Eyal Fenig(4), Neeraj Agarwal(4), Karim Fizazi(4), Célèste Lebbé(3), Paul Nathan(3), Josh Reed(3), Vijay Kasturi(3), Armin Rehm(3), Arun Azad(3), Nobuaki Matsubara(3), Robert J. Jones(3), Barbara Seliger(2), Paolo A. Ascierto(2), Rodrigo Ramella Munhoz(2), Elena Benincasa(2), Sarah Flaskett(2), Ricardo Hermosilla(2), Bernd Dörken(2)